DNA Profile
Ginkgo Bioworks Holdings, Inc. operates as a leading innovator in the field of synthetic biology, specializing in cell programming technologies. The company, through its advanced platform, enables the design and engineering of custom organisms for a wide array of applications. This platform is instrumental in programming cells to produce biological products, ranging from novel therapeutics and food ingredients to sustainable chemicals that traditionally rely on petroleum. By leveraging its proprietary technologies, Ginkgo Bioworks aims to revolutionize multiple industries by creating biologically-based solutions that enhance efficiency and sustainability.
Ginkgo Bioworks’ broad portfolio serves diverse end markets including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. The company’s capabilities extend across the entire lifecycle of cell programmingâ€from initial design to production and commercialization. This extensive application range underscores its commitment to advancing biotechnology and providing tailored solutions that address complex challenges in various sectors. The company's technology supports innovation in producing high-value products and reducing reliance on non-renewable resources.
The company has formed strategic partnerships to further its technological advancements, including a notable collaboration with Selecta Biosciences, Inc. This partnership focuses on developing the ImmTOR technology platform, which aims to improve immune tolerance and enhance the efficacy of biologic therapies. Such collaborations reflect Ginkgo Bioworks’ strategic approach to expanding its technological reach and accelerating the development of cutting-edge solutions in the biotechnology space.
Founded in 2008 and headquartered in Boston, Massachusetts, Ginkgo Bioworks Holdings, Inc. has established itself as a pioneer in the synthetic biology industry. The company's innovative approach and robust platform position it at the forefront of the biotechnology sector, driving advancements in cell programming and contributing to the evolution of numerous industries through biologically-based innovations.
|
